CSPC Pharmaceutical Group Top Insiders
| CHJTFDelisted Stock | USD 1.27 0.00 0.00% |
CSPC Pharmaceutical employs about 24.7 K people. The company is managed by 10 executives with a total tenure of roughly 95 years, averaging almost 9.0 years of service per executive, having 2474.6 employees per reported executive. Examination of CSPC Pharmaceutical's management performance can provide insight into the company performance.
| Dongchen Cai Chairman Executive Chairman, CEO, Managing Director and Chairman of Nomination Committee |
CSPC |
CSPC Pharmaceutical Management Team Effectiveness
The company has return on total asset (ROA) of 0.1157 % which means that it generated a profit of $0.1157 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2049 %, meaning that it generated $0.2049 on every $100 dollars invested by stockholders. CSPC Pharmaceutical's management efficiency ratios could be used to measure how well CSPC Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.CSPC Pharmaceutical Workforce Comparison
CSPC Pharmaceutical Group is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is currently estimated at about 197,841. CSPC Pharmaceutical retains roughly 24,746 in number of employees claiming about 13% of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22. CSPC Pharmaceutical Notable Stakeholders
A CSPC Pharmaceutical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CSPC Pharmaceutical often face trade-offs trying to please all of them. CSPC Pharmaceutical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CSPC Pharmaceutical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Dongchen Cai | Executive Chairman, CEO, Managing Director and Chairman of Nomination Committee | Profile | |
| Qingxi Wang | Executive Director | Profile | |
| Kin Chak | Executive Director | Profile | |
| Weidong Pan | Chief Accountant, Executive Director and Director of Shijiazhuang Pharmaceutical Group Company Limite | Profile | |
| Huaiyu Wang | Executive Director | Profile | |
| Jinxu Wang | Executive Director | Profile | |
| Chunlei Li | Executive Director | Profile | |
| Cuilong Zhang | Executive Director | Profile | |
| Zhenguo Wang | Executive Director | Profile | |
| Hao Jiang | Ex Director | Profile |
About CSPC Pharmaceutical Management Performance
The success or failure of an entity such as CSPC Pharmaceutical often depends on how effective the management is. CSPC Pharmaceutical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CSPC management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CSPC management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. Cspc Pharmaceuticals operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 25147 people.
CSPC Pharmaceutical Workforce Analysis
Traditionally, organizations such as CSPC Pharmaceutical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CSPC Pharmaceutical within its industry.CSPC Pharmaceutical Manpower Efficiency
Return on CSPC Pharmaceutical Manpower
| Revenue Per Employee | 1.1M | |
| Revenue Per Executive | 2.8B | |
| Net Income Per Employee | 226.5K | |
| Net Income Per Executive | 560.5M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in CSPC Pink Sheet
If you are still planning to invest in CSPC Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CSPC Pharmaceutical's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |